$SLS

$12.70▲ +4.4% YTD

6 SEC 13D/G filings tracked · Last updated Oct 28, 2026

Filing History

SLS ▲ +4.4% - SELLAS Life Sciences Group, Inc.

CP $12.70▲ +4.4%Oct 28, 2026 · ThinkSabio Blog

$SLS - SELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia…

SEC 13D/G

SLS - SELLAS Life Sciences Group, Inc. - SEC Filing Update (27-OCT-2026) | ThinkSabio - Stocks Simplified

$12.19▲ 181.52%Oct 27, 2026 · ThinkSabio Blog

$SLS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #SLS SELLAS Life Sciences Group, Inc. : $12.19 Sector: Healthcare…

News

SLS ▼ -2.0% - SELLAS Life Sciences Group, Inc.

CP $11.74▲ -2.0%Sep 25, 2026 · ThinkSabio Blog

$SLS - SELLAS Life Sciences Presents Preclinical Data Demonstrating SLS009 Activity in Pancreatic Cancer Models at the 2026 AACR Conference on Pancrea…

News

SLS ▲ +1.4% - SELLAS Life Sciences Group, Inc.

CP $13.33▲ +1.4%Sep 2, 2026 · ThinkSabio Blog

$SLS - SELLAS Life Sciences to Present Preclinical Data on SLS009 in Pancreatic Ductal Adenocarcinoma at the 2026 AACR Conference on Pancreatic Cancer…

News

SLS ▼ -1.2% - SELLAS Life Sciences Group, Inc.

CP $13.05▲ -1.2%Aug 31, 2026 · ThinkSabio Blog

$SLS - is in a quiet period but the CEO keeps posting on LinkedIn to keep his cult investors on the hook. -- ADAM F STAT News…

SEC 13D/G

$SLS SEC Filing Update (31-JUL-2026) | ThinkSabio - Stocks Simplified

$10.37▲ 139.49%Jul 31, 2026 · ThinkSabio Blog

$SLS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #SLS : $10.37 Sector: Healthcare | YTD: 🔼+ 139.49% The SEC disclo…